Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM is the Director of Vascular Intervention and an interventional cardiologist within the CardioVascular Institute at Beth Israel Deaconess Medical Center (BIDMC). He is also the Section Head of Interventional Cardiology and Vascular Research at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology and an Associate Professor of Medicine at Harvard Medical School. He received his medical degree from Northwestern University's Feinberg School of Medicine as part of the combined BA/MD pathway and a Master’s of Science in Epidemiology from the Harvard School of Public Health. Dr. Secemsky completed his internal medicine training at the University of California, San Francisco (UCSF), and Cardiovascular Medicine, Interventional Cardiology, and Vascular Diagnostics and Intervention training all at Massachusetts General Hospital (MGH)/Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures, with a focus on peripheral artery disease.

Dr. Secemsky's research involves utilizing real-world data to perform comparative effectiveness and outcomes research, with a focus on the treatment of coronary and peripheral vascular disorders. He has particular interests in drug delivery, intravascular imaging, antithrombotic therapy, renal denervation, and pulmonary embolism intervention. Dr. Secemsky is regarded as a world expert in clinical trial design, and has served in national leadership roles for more than two dozen clinical trials. Dr. Secemsky’s research program is funded by the National Institutes of Health (NIH), Harvard Medical School, the Food & Drug Administration, extramural grants and philanthropy. Dr. Secemsky has authored more than 375 publications and has mentored numerous medical students, residents, fellows and junior faculty. He is an Associate Editor at Circulation and is on the Editorial Board at Circulation: Cardiovascular Interventions, the Journal of SCAI and Vascular Medicine Journal. He was a writing member of the 2024 ACC/AHA Guideline on the Management of Lower Extremity Peripheral Artery Disease (PAD) and the 2026 ACC/AHA Guideline on the Management of Pulmonary Embolism. He serves as Treasurer for the Society for Vascular Medicine, the Co-Chair of SCAI's Vascular Disease Council and is on the Board of Directors for the VIVA Foundation and the PERT Consortium.